Pharmacokinetics of Noopept and its active metabolite cycloprolylglycine in rats
S. S. Boyko, V. P. Zherdev, R. V. Shevchenko · 2018 · Biomeditsinskaya Khimiya. 2018;64(5):455–458.
Study data at a glance
- Participants or experimental model
- Rat plasma and brain pharmacokinetic study.
- Reported results
- Cycloprolylglycine was found in rat plasma and brain and had a pharmacokinetic profile different from the parent drug. The paper relates these findings to memory-associated pharmacology.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Animal metabolite kinetics do not establish human exposure, cognitive benefit or a dosing interval.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Review depth: Primary-publication abstract and metadata; complete methods not appraised
Source access and review scope
Primary PubMed abstract and bibliographic metadata checked; full concentration-time tables not reviewed.
Recorded source-check date: 2026-11-01. This date does not imply a completed systematic review.
Source type: Journal publication
Citation and original source
Original source: S. S. Boyko, V. P. Zherdev, R. V. Shevchenko. Pharmacokinetics of Noopept and its active metabolite cycloprolylglycine in rats Biomeditsinskaya Khimiya. 2018;64(5):455–458. 2018.
Molekul research summary: https://molekul.io/research/noopept-metabolite-pk-2018. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry